Nishii Naohito, Nomizo Toru, Takashima Satoshi, Matsubara Tatsuya, Tokuda Masaaki, Kitagawa Hitoshi
Joint Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan.
J Vet Med Sci. 2016 Dec 1;78(11):1657-1662. doi: 10.1292/jvms.16-0302. Epub 2016 Jul 22.
D-allulose is a C-3 epimer of D-fructose and has recently been investigated for its hypoglycemic effects. In the present study, the effects of D-allulose on glucose metabolism were evaluated in healthy dogs administrated sugar or food. The oral administrations of D-allulose decreased plasma glucose concentrations after oral glucose or maltose administration, with a diminished plasma insulin rise. The glucose suppressive effect of D-allulose was also observed after intravenous glucose administrations without increase in plasma insulin concentration. In contrast, D-allulose showed no effect on plasma glucose and insulin concentrations after feeding. The present results suggest that D-allulose administration may be beneficial in dogs with impaired glucose tolerance. Further studies investigating the therapeutic efficacy of D-allulose in diabetic dogs are required.
D-阿洛酮糖是D-果糖的C-3差向异构体,最近已对其降血糖作用进行了研究。在本研究中,在给予糖或食物的健康犬中评估了D-阿洛酮糖对葡萄糖代谢的影响。口服D-阿洛酮糖可降低口服葡萄糖或麦芽糖后的血浆葡萄糖浓度,同时血浆胰岛素升高减弱。静脉注射葡萄糖后也观察到D-阿洛酮糖的葡萄糖抑制作用,且血浆胰岛素浓度未增加。相比之下,喂食后D-阿洛酮糖对血浆葡萄糖和胰岛素浓度无影响。目前的结果表明,给予D-阿洛酮糖可能对葡萄糖耐量受损的犬有益。需要进一步研究调查D-阿洛酮糖对糖尿病犬的治疗效果。